The global market for Dual-Antibody ADC was valued at US$ 522 million in the year 2024 and is projected to reach a revised size of US$ 736 million by 2031, growing at a CAGR of 5.7% during the forecast period.

Dual-Antibody ADC Market

Dual-Antibody ADC is an innovative targeted therapy that combines a bispecific antibody with a cytotoxic payload, enabling simultaneous recognition of two tumor-associated antigens and precise delivery of potent toxins to cancer cells. Compared to conventional ADCs, dual-antibody ADCs exhibit enhanced tumor selectivity and reduced off-target toxicity, potentially improving therapeutic efficacy while minimizing side effects. These drugs show promising applications in both hematological malignancies and solid tumors, representing a cutting-edge research focus in targeted cancer therapy.

North American market for Dual-Antibody ADC is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Dual-Antibody ADC is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Dual-Antibody ADC in Solid Tumors is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Dual-Antibody ADC include Sichuan Biokin Pharmaceutical, Doma Biopharmaceutical, VelaVigo, Hangzhou DAC Biotechnology, Biocy Togen, Innovent Biologics, Zymeworks, AstraZeneca, Regeneron Pharmaceuticals, Sutro Biopharma/Merck, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Dual-Antibody ADC, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dual-Antibody ADC.

The Dual-Antibody ADC market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dual-Antibody ADC market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Dual-Antibody ADC companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Dual-Antibody ADC Market Report

Report Metric	Details
Report Name	Dual-Antibody ADC Market
Accounted market size in year	US$ 522 million
Forecasted market size in 2031	US$ 736 million
CAGR	5.7%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Dual-Target ADC Dual-Epitope ADC
Segment by Application	Solid Tumors Non-Solid Tumors
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sichuan Biokin Pharmaceutical, Doma Biopharmaceutical, VelaVigo, Hangzhou DAC Biotechnology, Biocy Togen, Innovent Biologics, Zymeworks, AstraZeneca, Regeneron Pharmaceuticals, Sutro Biopharma/Merck, Alphamab Oncology, Coherent Biopharma, Sichuan Kelun Pharmaceutical, Akeso
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dual-Antibody ADC company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Dual-Antibody ADC Market growing?

Ans: The Dual-Antibody ADC Market witnessing a CAGR of 5.7% during the forecast period 2025-2031.

What is the Dual-Antibody ADC Market size in 2031?

Ans: The Dual-Antibody ADC Market size in 2031 will be US$ 736 million.

Who are the main players in the Dual-Antibody ADC Market report?

Ans: The main players in the Dual-Antibody ADC Market are Sichuan Biokin Pharmaceutical, Doma Biopharmaceutical, VelaVigo, Hangzhou DAC Biotechnology, Biocy Togen, Innovent Biologics, Zymeworks, AstraZeneca, Regeneron Pharmaceuticals, Sutro Biopharma/Merck, Alphamab Oncology, Coherent Biopharma, Sichuan Kelun Pharmaceutical, Akeso

What are the Application segmentation covered in the Dual-Antibody ADC Market report?

Ans: The Applications covered in the Dual-Antibody ADC Market report are Solid Tumors, Non-Solid Tumors

What are the Type segmentation covered in the Dual-Antibody ADC Market report?

Ans: The Types covered in the Dual-Antibody ADC Market report are Dual-Target ADC, Dual-Epitope ADC

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Dual-Antibody ADC Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Dual-Target ADC

1.2.3 Dual-Epitope ADC

1.3 Market by Application

1.3.1 Global Dual-Antibody ADC Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Solid Tumors

1.3.3 Non-Solid Tumors

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Dual-Antibody ADC Market Perspective (2020-2031)

2.2 Global Dual-Antibody ADC Growth Trends by Region

2.2.1 Global Dual-Antibody ADC Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Dual-Antibody ADC Historic Market Size by Region (2020-2025)

2.2.3 Dual-Antibody ADC Forecasted Market Size by Region (2026-2031)

2.3 Dual-Antibody ADC Market Dynamics

2.3.1 Dual-Antibody ADC Industry Trends

2.3.2 Dual-Antibody ADC Market Drivers

2.3.3 Dual-Antibody ADC Market Challenges

2.3.4 Dual-Antibody ADC Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Dual-Antibody ADC Players by Revenue

3.1.1 Global Top Dual-Antibody ADC Players by Revenue (2020-2025)

3.1.2 Global Dual-Antibody ADC Revenue Market Share by Players (2020-2025)

3.2 Global Top Dual-Antibody ADC Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Dual-Antibody ADC Revenue

3.4 Global Dual-Antibody ADC Market Concentration Ratio

3.4.1 Global Dual-Antibody ADC Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Dual-Antibody ADC Revenue in 2024

3.5 Global Key Players of Dual-Antibody ADC Head office and Area Served

3.6 Global Key Players of Dual-Antibody ADC, Product and Application

3.7 Global Key Players of Dual-Antibody ADC, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Dual-Antibody ADC Breakdown Data by Type

4.1 Global Dual-Antibody ADC Historic Market Size by Type (2020-2025)

4.2 Global Dual-Antibody ADC Forecasted Market Size by Type (2026-2031)

5 Dual-Antibody ADC Breakdown Data by Application

5.1 Global Dual-Antibody ADC Historic Market Size by Application (2020-2025)

5.2 Global Dual-Antibody ADC Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Dual-Antibody ADC Market Size (2020-2031)

6.2 North America Dual-Antibody ADC Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Dual-Antibody ADC Market Size by Country (2020-2025)

6.4 North America Dual-Antibody ADC Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Dual-Antibody ADC Market Size (2020-2031)

7.2 Europe Dual-Antibody ADC Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Dual-Antibody ADC Market Size by Country (2020-2025)

7.4 Europe Dual-Antibody ADC Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Dual-Antibody ADC Market Size (2020-2031)

8.2 Asia-Pacific Dual-Antibody ADC Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Dual-Antibody ADC Market Size by Region (2020-2025)

8.4 Asia-Pacific Dual-Antibody ADC Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Dual-Antibody ADC Market Size (2020-2031)

9.2 Latin America Dual-Antibody ADC Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Dual-Antibody ADC Market Size by Country (2020-2025)

9.4 Latin America Dual-Antibody ADC Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Dual-Antibody ADC Market Size (2020-2031)

10.2 Middle East & Africa Dual-Antibody ADC Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Dual-Antibody ADC Market Size by Country (2020-2025)

10.4 Middle East & Africa Dual-Antibody ADC Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Sichuan Biokin Pharmaceutical

11.1.1 Sichuan Biokin Pharmaceutical Company Details

11.1.2 Sichuan Biokin Pharmaceutical Business Overview

11.1.3 Sichuan Biokin Pharmaceutical Dual-Antibody ADC Introduction

11.1.4 Sichuan Biokin Pharmaceutical Revenue in Dual-Antibody ADC Business (2020-2025)

11.1.5 Sichuan Biokin Pharmaceutical Recent Development

11.2 Doma Biopharmaceutical

11.2.1 Doma Biopharmaceutical Company Details

11.2.2 Doma Biopharmaceutical Business Overview

11.2.3 Doma Biopharmaceutical Dual-Antibody ADC Introduction

11.2.4 Doma Biopharmaceutical Revenue in Dual-Antibody ADC Business (2020-2025)

11.2.5 Doma Biopharmaceutical Recent Development

11.3 VelaVigo

11.3.1 VelaVigo Company Details

11.3.2 VelaVigo Business Overview

11.3.3 VelaVigo Dual-Antibody ADC Introduction

11.3.4 VelaVigo Revenue in Dual-Antibody ADC Business (2020-2025)

11.3.5 VelaVigo Recent Development

11.4 Hangzhou DAC Biotechnology

11.4.1 Hangzhou DAC Biotechnology Company Details

11.4.2 Hangzhou DAC Biotechnology Business Overview

11.4.3 Hangzhou DAC Biotechnology Dual-Antibody ADC Introduction

11.4.4 Hangzhou DAC Biotechnology Revenue in Dual-Antibody ADC Business (2020-2025)

11.4.5 Hangzhou DAC Biotechnology Recent Development

11.5 Biocy Togen

11.5.1 Biocy Togen Company Details

11.5.2 Biocy Togen Business Overview

11.5.3 Biocy Togen Dual-Antibody ADC Introduction

11.5.4 Biocy Togen Revenue in Dual-Antibody ADC Business (2020-2025)

11.5.5 Biocy Togen Recent Development

11.6 Innovent Biologics

11.6.1 Innovent Biologics Company Details

11.6.2 Innovent Biologics Business Overview

11.6.3 Innovent Biologics Dual-Antibody ADC Introduction

11.6.4 Innovent Biologics Revenue in Dual-Antibody ADC Business (2020-2025)

11.6.5 Innovent Biologics Recent Development

11.7 Zymeworks

11.7.1 Zymeworks Company Details

11.7.2 Zymeworks Business Overview

11.7.3 Zymeworks Dual-Antibody ADC Introduction

11.7.4 Zymeworks Revenue in Dual-Antibody ADC Business (2020-2025)

11.7.5 Zymeworks Recent Development

11.8 AstraZeneca

11.8.1 AstraZeneca Company Details

11.8.2 AstraZeneca Business Overview

11.8.3 AstraZeneca Dual-Antibody ADC Introduction

11.8.4 AstraZeneca Revenue in Dual-Antibody ADC Business (2020-2025)

11.8.5 AstraZeneca Recent Development

11.9 Regeneron Pharmaceuticals

11.9.1 Regeneron Pharmaceuticals Company Details

11.9.2 Regeneron Pharmaceuticals Business Overview

11.9.3 Regeneron Pharmaceuticals Dual-Antibody ADC Introduction

11.9.4 Regeneron Pharmaceuticals Revenue in Dual-Antibody ADC Business (2020-2025)

11.9.5 Regeneron Pharmaceuticals Recent Development

11.10 Sutro Biopharma/Merck

11.10.1 Sutro Biopharma/Merck Company Details

11.10.2 Sutro Biopharma/Merck Business Overview

11.10.3 Sutro Biopharma/Merck Dual-Antibody ADC Introduction

11.10.4 Sutro Biopharma/Merck Revenue in Dual-Antibody ADC Business (2020-2025)

11.10.5 Sutro Biopharma/Merck Recent Development

11.11 Alphamab Oncology

11.11.1 Alphamab Oncology Company Details

11.11.2 Alphamab Oncology Business Overview

11.11.3 Alphamab Oncology Dual-Antibody ADC Introduction

11.11.4 Alphamab Oncology Revenue in Dual-Antibody ADC Business (2020-2025)

11.11.5 Alphamab Oncology Recent Development

11.12 Coherent Biopharma

11.12.1 Coherent Biopharma Company Details

11.12.2 Coherent Biopharma Business Overview

11.12.3 Coherent Biopharma Dual-Antibody ADC Introduction

11.12.4 Coherent Biopharma Revenue in Dual-Antibody ADC Business (2020-2025)

11.12.5 Coherent Biopharma Recent Development

11.13 Sichuan Kelun Pharmaceutical

11.13.1 Sichuan Kelun Pharmaceutical Company Details

11.13.2 Sichuan Kelun Pharmaceutical Business Overview

11.13.3 Sichuan Kelun Pharmaceutical Dual-Antibody ADC Introduction

11.13.4 Sichuan Kelun Pharmaceutical Revenue in Dual-Antibody ADC Business (2020-2025)

11.13.5 Sichuan Kelun Pharmaceutical Recent Development

11.14 Akeso

11.14.1 Akeso Company Details

11.14.2 Akeso Business Overview

11.14.3 Akeso Dual-Antibody ADC Introduction

11.14.4 Akeso Revenue in Dual-Antibody ADC Business (2020-2025)

11.14.5 Akeso Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Sichuan Biokin Pharmaceutical

Doma Biopharmaceutical

Innovent Biologics

ZymeWorks

Astrazeneca plc

Regeneron Pharmaceuticals

ALPHAMAB ONCOLOGY

Sichuan Kelun Pharmaceutical

Akeso, Inc.

VelaVigo

Hangzhou DAC Biotechnology

Biocy Togen

Sutro Biopharma/Merck

Coherent Biopharma

List of Tables

Table 1. Global Dual-Antibody ADC Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Dual-Target ADC

Table 3. Key Players of Dual-Epitope ADC

Table 4. Global Dual-Antibody ADC Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Dual-Antibody ADC Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Dual-Antibody ADC Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Dual-Antibody ADC Market Share by Region (2020-2025)

Table 8. Global Dual-Antibody ADC Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Dual-Antibody ADC Market Share by Region (2026-2031)

Table 10. Dual-Antibody ADC Market Trends

Table 11. Dual-Antibody ADC Market Drivers

Table 12. Dual-Antibody ADC Market Challenges

Table 13. Dual-Antibody ADC Market Restraints

Table 14. Global Dual-Antibody ADC Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Dual-Antibody ADC Market Share by Players (2020-2025)

Table 16. Global Top Dual-Antibody ADC Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dual-Antibody ADC as of 2024)

Table 17. Ranking of Global Top Dual-Antibody ADC Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Dual-Antibody ADC Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Dual-Antibody ADC, Headquarters and Area Served

Table 20. Global Key Players of Dual-Antibody ADC, Product and Application

Table 21. Global Key Players of Dual-Antibody ADC, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Dual-Antibody ADC Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Dual-Antibody ADC Revenue Market Share by Type (2020-2025)

Table 25. Global Dual-Antibody ADC Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Dual-Antibody ADC Revenue Market Share by Type (2026-2031)

Table 27. Global Dual-Antibody ADC Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Dual-Antibody ADC Revenue Market Share by Application (2020-2025)

Table 29. Global Dual-Antibody ADC Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Dual-Antibody ADC Revenue Market Share by Application (2026-2031)

Table 31. North America Dual-Antibody ADC Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Dual-Antibody ADC Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Dual-Antibody ADC Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Dual-Antibody ADC Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Dual-Antibody ADC Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Dual-Antibody ADC Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Dual-Antibody ADC Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Dual-Antibody ADC Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Dual-Antibody ADC Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Dual-Antibody ADC Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Dual-Antibody ADC Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Dual-Antibody ADC Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Dual-Antibody ADC Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Dual-Antibody ADC Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Dual-Antibody ADC Market Size by Country (2026-2031) & (US$ Million)

Table 46. Sichuan Biokin Pharmaceutical Company Details

Table 47. Sichuan Biokin Pharmaceutical Business Overview

Table 48. Sichuan Biokin Pharmaceutical Dual-Antibody ADC Product

Table 49. Sichuan Biokin Pharmaceutical Revenue in Dual-Antibody ADC Business (2020-2025) & (US$ Million)

Table 50. Sichuan Biokin Pharmaceutical Recent Development

Table 51. Doma Biopharmaceutical Company Details

Table 52. Doma Biopharmaceutical Business Overview

Table 53. Doma Biopharmaceutical Dual-Antibody ADC Product

Table 54. Doma Biopharmaceutical Revenue in Dual-Antibody ADC Business (2020-2025) & (US$ Million)

Table 55. Doma Biopharmaceutical Recent Development

Table 56. VelaVigo Company Details

Table 57. VelaVigo Business Overview

Table 58. VelaVigo Dual-Antibody ADC Product

Table 59. VelaVigo Revenue in Dual-Antibody ADC Business (2020-2025) & (US$ Million)

Table 60. VelaVigo Recent Development

Table 61. Hangzhou DAC Biotechnology Company Details

Table 62. Hangzhou DAC Biotechnology Business Overview

Table 63. Hangzhou DAC Biotechnology Dual-Antibody ADC Product

Table 64. Hangzhou DAC Biotechnology Revenue in Dual-Antibody ADC Business (2020-2025) & (US$ Million)

Table 65. Hangzhou DAC Biotechnology Recent Development

Table 66. Biocy Togen Company Details

Table 67. Biocy Togen Business Overview

Table 68. Biocy Togen Dual-Antibody ADC Product

Table 69. Biocy Togen Revenue in Dual-Antibody ADC Business (2020-2025) & (US$ Million)

Table 70. Biocy Togen Recent Development

Table 71. Innovent Biologics Company Details

Table 72. Innovent Biologics Business Overview

Table 73. Innovent Biologics Dual-Antibody ADC Product

Table 74. Innovent Biologics Revenue in Dual-Antibody ADC Business (2020-2025) & (US$ Million)

Table 75. Innovent Biologics Recent Development

Table 76. Zymeworks Company Details

Table 77. Zymeworks Business Overview

Table 78. Zymeworks Dual-Antibody ADC Product

Table 79. Zymeworks Revenue in Dual-Antibody ADC Business (2020-2025) & (US$ Million)

Table 80. Zymeworks Recent Development

Table 81. AstraZeneca Company Details

Table 82. AstraZeneca Business Overview

Table 83. AstraZeneca Dual-Antibody ADC Product

Table 84. AstraZeneca Revenue in Dual-Antibody ADC Business (2020-2025) & (US$ Million)

Table 85. AstraZeneca Recent Development

Table 86. Regeneron Pharmaceuticals Company Details

Table 87. Regeneron Pharmaceuticals Business Overview

Table 88. Regeneron Pharmaceuticals Dual-Antibody ADC Product

Table 89. Regeneron Pharmaceuticals Revenue in Dual-Antibody ADC Business (2020-2025) & (US$ Million)

Table 90. Regeneron Pharmaceuticals Recent Development

Table 91. Sutro Biopharma/Merck Company Details

Table 92. Sutro Biopharma/Merck Business Overview

Table 93. Sutro Biopharma/Merck Dual-Antibody ADC Product

Table 94. Sutro Biopharma/Merck Revenue in Dual-Antibody ADC Business (2020-2025) & (US$ Million)

Table 95. Sutro Biopharma/Merck Recent Development

Table 96. Alphamab Oncology Company Details

Table 97. Alphamab Oncology Business Overview

Table 98. Alphamab Oncology Dual-Antibody ADC Product

Table 99. Alphamab Oncology Revenue in Dual-Antibody ADC Business (2020-2025) & (US$ Million)

Table 100. Alphamab Oncology Recent Development

Table 101. Coherent Biopharma Company Details

Table 102. Coherent Biopharma Business Overview

Table 103. Coherent Biopharma Dual-Antibody ADC Product

Table 104. Coherent Biopharma Revenue in Dual-Antibody ADC Business (2020-2025) & (US$ Million)

Table 105. Coherent Biopharma Recent Development

Table 106. Sichuan Kelun Pharmaceutical Company Details

Table 107. Sichuan Kelun Pharmaceutical Business Overview

Table 108. Sichuan Kelun Pharmaceutical Dual-Antibody ADC Product

Table 109. Sichuan Kelun Pharmaceutical Revenue in Dual-Antibody ADC Business (2020-2025) & (US$ Million)

Table 110. Sichuan Kelun Pharmaceutical Recent Development

Table 111. Akeso Company Details

Table 112. Akeso Business Overview

Table 113. Akeso Dual-Antibody ADC Product

Table 114. Akeso Revenue in Dual-Antibody ADC Business (2020-2025) & (US$ Million)

Table 115. Akeso Recent Development

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

Table 119. Authors List of This Report

List of Figures

Figure 1. Dual-Antibody ADC Picture

Figure 2. Global Dual-Antibody ADC Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Dual-Antibody ADC Market Share by Type: 2024 VS 2031

Figure 4. Dual-Target ADC Features

Figure 5. Dual-Epitope ADC Features

Figure 6. Global Dual-Antibody ADC Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Dual-Antibody ADC Market Share by Application: 2024 VS 2031

Figure 8. Solid Tumors Case Studies

Figure 9. Non-Solid Tumors Case Studies

Figure 10. Dual-Antibody ADC Report Years Considered

Figure 11. Global Dual-Antibody ADC Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 12. Global Dual-Antibody ADC Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Dual-Antibody ADC Market Share by Region: 2024 VS 2031

Figure 14. Global Dual-Antibody ADC Market Share by Players in 2024

Figure 15. Global Dual-Antibody ADC Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 16. The Top 10 and 5 Players Market Share by Dual-Antibody ADC Revenue in 2024

Figure 17. North America Dual-Antibody ADC Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 18. North America Dual-Antibody ADC Market Share by Country (2020-2031)

Figure 19. United States Dual-Antibody ADC Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. Canada Dual-Antibody ADC Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Europe Dual-Antibody ADC Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Dual-Antibody ADC Market Share by Country (2020-2031)

Figure 23. Germany Dual-Antibody ADC Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. France Dual-Antibody ADC Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. U.K. Dual-Antibody ADC Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Italy Dual-Antibody ADC Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Russia Dual-Antibody ADC Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Nordic Countries Dual-Antibody ADC Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Asia-Pacific Dual-Antibody ADC Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Dual-Antibody ADC Market Share by Region (2020-2031)

Figure 31. China Dual-Antibody ADC Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Japan Dual-Antibody ADC Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. South Korea Dual-Antibody ADC Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Southeast Asia Dual-Antibody ADC Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. India Dual-Antibody ADC Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Australia Dual-Antibody ADC Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Latin America Dual-Antibody ADC Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Dual-Antibody ADC Market Share by Country (2020-2031)

Figure 39. Mexico Dual-Antibody ADC Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Brazil Dual-Antibody ADC Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Middle East & Africa Dual-Antibody ADC Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Dual-Antibody ADC Market Share by Country (2020-2031)

Figure 43. Turkey Dual-Antibody ADC Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Saudi Arabia Dual-Antibody ADC Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. UAE Dual-Antibody ADC Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Sichuan Biokin Pharmaceutical Revenue Growth Rate in Dual-Antibody ADC Business (2020-2025)

Figure 47. Doma Biopharmaceutical Revenue Growth Rate in Dual-Antibody ADC Business (2020-2025)

Figure 48. VelaVigo Revenue Growth Rate in Dual-Antibody ADC Business (2020-2025)

Figure 49. Hangzhou DAC Biotechnology Revenue Growth Rate in Dual-Antibody ADC Business (2020-2025)

Figure 50. Biocy Togen Revenue Growth Rate in Dual-Antibody ADC Business (2020-2025)

Figure 51. Innovent Biologics Revenue Growth Rate in Dual-Antibody ADC Business (2020-2025)

Figure 52. Zymeworks Revenue Growth Rate in Dual-Antibody ADC Business (2020-2025)

Figure 53. AstraZeneca Revenue Growth Rate in Dual-Antibody ADC Business (2020-2025)

Figure 54. Regeneron Pharmaceuticals Revenue Growth Rate in Dual-Antibody ADC Business (2020-2025)

Figure 55. Sutro Biopharma/Merck Revenue Growth Rate in Dual-Antibody ADC Business (2020-2025)

Figure 56. Alphamab Oncology Revenue Growth Rate in Dual-Antibody ADC Business (2020-2025)

Figure 57. Coherent Biopharma Revenue Growth Rate in Dual-Antibody ADC Business (2020-2025)

Figure 58. Sichuan Kelun Pharmaceutical Revenue Growth Rate in Dual-Antibody ADC Business (2020-2025)

Figure 59. Akeso Revenue Growth Rate in Dual-Antibody ADC Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Antibody Drug Conjugate CDMO Market Research Report 2024

Antibody drug Conjugate for Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Antibody drug Conjugates Market Insights Forecast to 2030

Global Antibody drug Conjugate ADC Payload Market Research Report 2025

Global HER2 Antibody Drug Conjugate Market Research Report 2025

Global Antibody drug Conjugates for Tumors Market Research Report 2024

Global ADC Linkers Market Research Report 2024

Global Antibody drug Conjugates ADCs CMO and CDMO Market Research Report 2025

Global Antibody Drug Conjugates Contract Manufacturing Market Research Report 2025

ADC Platform Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global HER2 ADC Drugs Market Research Report 2024

Global Bispecific Antibodies for Cancer Market Insights Forecast to 2030

Global Highly Potent API HPAPI For Antibody drug Conjugate ADC Market Research Report 2025

Antibody Drug Conjugate ADC Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global ADC Drug CDMO Service Market Research Report 2024

Global Next Generation Antibody Therapeutics Market Research Report 2025

Global ADC Manufacturing Service Market Research Report 2025

Global Bispecific Antibody Molecular Drug Market Research Report 2025

Global Bispecific Antibody Development Platform Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions